Market Cap 255.04M
Revenue (ttm) 31.02M
Net Income (ttm) -57.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -186.46%
Debt to Equity Ratio 0.00
Volume 19,683,324
Avg Vol 341,078
Day's Range N/A - N/A
Shares Out 100.41M
Stochastic %K 50%
Beta 1.60
Analysts Strong Sell
Price Target $9.00

Company Profile

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It develops Crenezumab, a humanized, confor...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 21 345 91 21
Fax: 41 21 345 91 20
Address:
Building B, EPFL Innovation Park, Lausanne, Switzerland
Urim8
Urim8 Dec. 11 at 8:46 PM
$ACIU Will we see a candle before the end of trading?
0 · Reply
BioTuesdays
BioTuesdays Dec. 11 at 8:08 PM
$ACIU has announced positive interim safety and efficacy results from the Phase 2 VacSYn trial of its wholly-owned anti-alpha-synuclein (a-syn) active immunotherapy, ACI-7104.056, in early Parkinson’s disease (PD) https://biotuesdays.com/2025/12/11/ac-immune-reports-positive-interim-data-of-a-syn-active-immunotherapy-in-early-pd/
0 · Reply
Moonopolys
Moonopolys Dec. 11 at 8:07 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $LAES $MNTS $MARA $ACIU $PATH
0 · Reply
wyoming2020
wyoming2020 Dec. 11 at 7:48 PM
0 · Reply
Oggggg
Oggggg Dec. 11 at 7:39 PM
$ACIU AH 🚀
0 · Reply
Raisehellpraisedale
Raisehellpraisedale Dec. 11 at 6:56 PM
$ACIU given a significant average volume increase over the next 7 days, I can’t see any why this wouldn’t be a 20% or more short term swing. The thesis for holding long is fairly obvious so I’m just talking about a run of accumulation and melting upwards continuously. I like the odds here
0 · Reply
loganadams_99
loganadams_99 Dec. 11 at 5:54 PM
$ACIU small biotech with Alzheimer angle, any credible data or partnership can completely reset the valuation
0 · Reply
OdinTrades663
OdinTrades663 Dec. 11 at 5:34 PM
$ACIU just dropped a catalyst and looking at the options chain there is now over 4,500 contracts stacked on the $5 calls with crazy high IV, barely any put action, and a clear call skew. Basically, looks like people are betting hard on a run toward $3.75–$5.00 by Dec 19. The company says it’s funded through Q3 2027, but the $200M shelf is still live, so management could also be selling into strength. This looks like could be volatile until options because everyone is chasing upside, but dilution risk keeps capping the move. Worth keeping an eye on the options chain if trading this! JMO DYOR
1 · Reply
alecsalaur198
alecsalaur198 Dec. 11 at 5:07 PM
$ACIU let s go
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 11 at 5:02 PM
Dumbo reporting in! $ACIU just popped 3% higher to 11% (~17Mv) a few minutes ago, 12/19 options, follow for more volatility.
0 · Reply
Latest News on ACIU
Alzheimer's vaccine licensing deal boosts AC Immune

May 13, 2024, 8:47 AM EDT - 1 year ago

Alzheimer's vaccine licensing deal boosts AC Immune


AC Immune Announces Upcoming Presentations at AD/PD™ 2024

Feb 22, 2024, 7:00 AM EST - 1 year ago

AC Immune Announces Upcoming Presentations at AD/PD™ 2024


AC Immune to Regain Global Rights to Crenezumab and Semorinemab

Jan 22, 2024, 7:00 AM EST - 2 years ago

AC Immune to Regain Global Rights to Crenezumab and Semorinemab


AC Immune SA Appoints New Chief Medical Officer

Jul 26, 2023, 7:00 AM EDT - 2 years ago

AC Immune SA Appoints New Chief Medical Officer


AC Immune Showcasing Precision Medicine Programs at AAIC 2023

Jul 3, 2023, 7:00 AM EDT - 2 years ago

AC Immune Showcasing Precision Medicine Programs at AAIC 2023


Why Shares of AC Immune Jumped This Week

Jun 30, 2023, 3:13 PM EDT - 2 years ago

Why Shares of AC Immune Jumped This Week


AC Immune Holds Annual General Meeting of Shareholders

Jun 23, 2023, 4:30 PM EDT - 2 years ago

AC Immune Holds Annual General Meeting of Shareholders


Urim8
Urim8 Dec. 11 at 8:46 PM
$ACIU Will we see a candle before the end of trading?
0 · Reply
BioTuesdays
BioTuesdays Dec. 11 at 8:08 PM
$ACIU has announced positive interim safety and efficacy results from the Phase 2 VacSYn trial of its wholly-owned anti-alpha-synuclein (a-syn) active immunotherapy, ACI-7104.056, in early Parkinson’s disease (PD) https://biotuesdays.com/2025/12/11/ac-immune-reports-positive-interim-data-of-a-syn-active-immunotherapy-in-early-pd/
0 · Reply
Moonopolys
Moonopolys Dec. 11 at 8:07 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $LAES $MNTS $MARA $ACIU $PATH
0 · Reply
wyoming2020
wyoming2020 Dec. 11 at 7:48 PM
0 · Reply
Oggggg
Oggggg Dec. 11 at 7:39 PM
$ACIU AH 🚀
0 · Reply
Raisehellpraisedale
Raisehellpraisedale Dec. 11 at 6:56 PM
$ACIU given a significant average volume increase over the next 7 days, I can’t see any why this wouldn’t be a 20% or more short term swing. The thesis for holding long is fairly obvious so I’m just talking about a run of accumulation and melting upwards continuously. I like the odds here
0 · Reply
loganadams_99
loganadams_99 Dec. 11 at 5:54 PM
$ACIU small biotech with Alzheimer angle, any credible data or partnership can completely reset the valuation
0 · Reply
OdinTrades663
OdinTrades663 Dec. 11 at 5:34 PM
$ACIU just dropped a catalyst and looking at the options chain there is now over 4,500 contracts stacked on the $5 calls with crazy high IV, barely any put action, and a clear call skew. Basically, looks like people are betting hard on a run toward $3.75–$5.00 by Dec 19. The company says it’s funded through Q3 2027, but the $200M shelf is still live, so management could also be selling into strength. This looks like could be volatile until options because everyone is chasing upside, but dilution risk keeps capping the move. Worth keeping an eye on the options chain if trading this! JMO DYOR
1 · Reply
alecsalaur198
alecsalaur198 Dec. 11 at 5:07 PM
$ACIU let s go
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 11 at 5:02 PM
Dumbo reporting in! $ACIU just popped 3% higher to 11% (~17Mv) a few minutes ago, 12/19 options, follow for more volatility.
0 · Reply
merlin8121
merlin8121 Dec. 11 at 4:46 PM
$ACIU https://www.merlintrader.com/aciu-ac-immune/
0 · Reply
mikesterz7
mikesterz7 Dec. 11 at 4:35 PM
$ACIU The trial results showed for the first time that active immunotherapy targeting a-syn pathology could slow the progression of Parkinson’s disease. The interim results from the study showed a 100% responder rate for all targets.
0 · Reply
lololosserer
lololosserer Dec. 11 at 4:35 PM
$ACIU scam, run
1 · Reply
Awesom69Trade
Awesom69Trade Dec. 11 at 3:58 PM
$ACIU Once investors and HF analysts all data. They be scooping up at this low price. I wish I have more fund to add.
0 · Reply
GinoLedgeee
GinoLedgeee Dec. 11 at 3:51 PM
$ACIU Back to 2.80 by end of day
0 · Reply
prismmarketview
prismmarketview Dec. 11 at 3:41 PM
AC Immune ( $ACIU) is rallying after interim Phase 2 VacSYn data showed its anti‑alpha‑synuclein vaccine ACI‑7104.056 hit all immunogenicity targets with a 100% responder rate, stabilized key PD biomarkers vs. placebo, and maintained a clean safety profile—supporting a potential disease‑slowing effect in early Parkinson’s. https://prismmarketview.com/ac-immune-posts-strong-phase-2-interim-data-for-aci-7104-056-in-parkinsons-disease/
0 · Reply
leonp123
leonp123 Dec. 11 at 3:40 PM
0 · Reply
JanetBSmellin
JanetBSmellin Dec. 11 at 3:13 PM
0 · Reply
earf
earf Dec. 11 at 3:10 PM
$ACIU Hopp Dietmar. https://www.labiotech.eu/trends-news/ac-immune-alzheimers-ipo/
0 · Reply
SHEEPWOLF
SHEEPWOLF Dec. 11 at 3:06 PM
$ACIU nice turn
0 · Reply
OdinTrades663
OdinTrades663 Dec. 11 at 3:06 PM
$ACIU My thoughts - Circa 15M shares traded (15% of ACIU’s 99M float), they could have already pushed through roughly $44M at an average $3 price if the ATM is active, meaning nearly half of a likely $100M raise is already absorbed in a single session; at this liquidity, they could realistically finish the rest over the next few days, so while the $200M shelf remains live until exhausted or expired, the practical “turn‑off” point for the ATM, IMO, comes once they’ve secured 2–3 years of runway ($80–100M), after which they’d pause issuance. JMO DYOR
2 · Reply
alecsalaur198
alecsalaur198 Dec. 11 at 3:06 PM
$ACIU seems like a solid hold
0 · Reply